Britain to provide anti-viral drug remdesivir to some COVID-19 patients
LONDON: Britain will provide the anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a ...
WorldBritain's Health Secretary Matt Hancock holds the daily coronavirus news conference at 10 Downing Street in London. (Pippa Fowles/10 Downing Street/Handout via REUTERS)27 May 2020 12:57AMShare this contentBookmarkLONDON: Britain will provide the anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a collaboration with manufacturer Gilead Sciences, the health ministry said on Tuesday (May 26).
The department of health said early data from clinical trials around the world showed that the drug could shorten the recovery time of COVID-19 patients by four days.AdvertisementAdvertisement"This is probably the biggest step forward in the treatment of coronavirus since the crisis began," health minister Matt Hancock told a government news conference.
"These are very early steps, but we are determined to support the science and back the projects that show promise."The government said the allocation of the drug would be determined by where it would have the greatest benefit, but did not say how many patients would be treated.
The US National Institutes of Health (NIH) said last week that data from its trial of remdesivir showed that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.AdvertisementAdvertisement
The researchers also said that"given high mortality despite the use of remdesivir," it is likely that the drug would be more effective in combination with other treatments for COVID-19, the respiratory illness caused by the novel coronavirus.
Stephen Griffin, an associate professor at Leeds University, welcomed the move to use remdesivir, saying it would"likely mean that the most severe COVID-19 patients will receive it first". He said that while this approach was the most ethical, it also meant drug would not be a"magic bullet".
"We can instead hope for improved recovery rates and a reduction in patient mortality," Griffin said. Read more: CNA »
Britain to provide anti-viral drug remdesivir to some COVID-19 patientsBritain will provide anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a collaboration with ... the question will be how safe is it?
Britain revises up COVID-19-related deaths to 46,000LONDON: Britain's number of deaths 'involving' COVID-19 has risen to 46,000, substantially higher than the 36,914 fatalities officially reported ...
344 new Covid-19 cases in Singapore, tally stands at 31,960SINGAPORE — Singapore has confirmed 344 new cases of Covid-19, said the Ministry of Health (MOH) in a press release on Monday (May 25).
Thailand reports 2 new COVID-19 cases, 1 more deathThailand confirmed two new coronavirus cases and one additional death on Monday, a health ministry spokesman said.
Hyphens Pharma revs up digital push amid Covid-19HAVING transformed its traditional wholesale business into an online medical hypermart two decades ago, Hyphens Pharma International is now reaping the benefits of its digital strategy. The company, which sells pharmaceuticals and other consumer healthcare products, is now exploring how digital technology can aid other segments of its business too. Read more at The Business Times.
Americans pass pandemic holiday on beaches, in parks as COVID-19 death toll nears 100,000Americans sunbathed on beaches, fished from boats and strolled on boardwalks this holiday weekend, but the occasional person wearing a mask was a ... Never mind... its already too long, duboleh thahaan any more..